Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer.

Pauli, Griffin; Chao, Po-Han; Qin, Zhu; Böttger, Roland; Lee, Suen Ern; Li, Shyh-Dar

Pauli, Griffin; Chao, Po-Han; Qin, Zhu; Böttger, Roland; Lee, Suen Ern; Li, Shyh-Dar.

Afiliação

Pauli G; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Chao PH; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Qin Z; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Böttger R; Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China.
Lee SE; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Li SD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Pharmaceutics ; 13(10)2021 Oct 15.

Article em En | MEDLINE | ID: mdl-34683992

Palavras-chave

drug delivery; immunotherapy; liposomes; peritoneal metastasis of cancer; resiquimod; toll-like receptor agonist

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá